Caspase-3-like activity is necessary for IL-2 release in activated Jurkat T-cells

Experimental Cell Research

Volumn 244, Issue 1, 1998, Pages 302-309

  Posmantur, Rand ^a,b   Wang, Kevin K W ^a   Gilbertsen, Richard B ^a  

^a PFIZER INC   (United States)

^b BRISTOL MYERS SQUIBB   (United States)

Author keywords

Activation; Apoptosis; Caspase 3; Interleukin 2; Jurkat

Indexed keywords

CD28 ANTIGEN; CD3 ANTIGEN; ENZYME INHIBITOR; INTERLEUKIN 1BETA CONVERTING ENZYME; INTERLEUKIN 2; LACTATE DEHYDROGENASE; PHYTOHEMAGGLUTININ;

APOPTOSIS; ARTICLE; CELL DEATH; CONTROLLED STUDY; ENZYME ACTIVITY; ENZYME INHIBITION; HUMAN; HUMAN CELL; LEUKEMIA CELL LINE; PRIORITY JOURNAL; PROTEIN DEGRADATION; T LYMPHOCYTE ACTIVATION;

EID: 0032505751     PISSN: 00144827     EISSN: None     Source Type: Journal    
DOI: 10.1006/excr.1998.4214     Document Type: Article

References (54)

1. Miossec, C., Dutilleul, V., Fassay, F., and Diu-Hercend, A. (1997). Evidence for CPP32 activation in the absence of apoptosis during T lymphocyte stimulation. J. Biol Chem. 272, 13459-13462.
2. Zapata, J. M., Takahashi, R., Salvesen, G. S., and Reed, J. C. (1998). Granzyme release and caspase activation in activated human T-Lymphocytes. J. Biol Chem. 273, 6916-6920.
3. Fraser, A., and Evan, G. (1996). A license to kill. Cell 85, 781-784.
4. Vaux, D. L., and Strasser, A. (1996). The molecular biology of apoptosis. Proc. Natl. Acad. Sci. USA 93, 2239-2244.
5. Alnemri, E. S., Livingston, D. J., Nicholson, D. W., Salvesen, G., Thornberry, N. A., Wong, W. W., and Yuan, J. (1996). Human ICE/CED-3 protease nomenclature. Cell 87, 171.
6. Muzio, M., Salvesen, G. S., and Dixit, V. M. (1997). FLICE induced apoptosis in a cell-free system. Cleavage of caspase zymogens. J. Biol. Chem. 272, 2952-2956.
7. Homma, S., Yaginuma, H., and Oppenheim, R. W. (1994). Programmed cell death during the earliest stages of spinal cord development in the chick embryo: A possible means of early phenotypic selection. J. Comp. Neurol. 345, 377-395.
8. Zamenhof, S., and Guthrie, D. (1995). Programmed cell death enhances uniformity in rat cerebral hemispheres. Dev. Neurosci. 17, 264-266.
9. Yaginuma, H., Tomita, M., Takashita, N., McKay, S. E., Cardwell, C., Yin, Q. W., and Oppenheim, R. W. (1996). A novel type of programmed neuronal death in the cervical spinal cord of the chick embryo. J. Neurosci. 16, 3685-3703.
10. Kirshenbaum, L. A., and de Moissac, D. (1997). The bcl-2 gene product prevents programmed cell death of ventricular myocytes. Circulation 96, 1580-1585.
11. Kappler, J. W., Roehm, N., and Marrack, P. (1987). T-cell tolerance by clonal elimination in the thymus. Cell 49, 273-280.
12. von Boehmer, H. (1994). Positive selection of lymphocytes. Cell 76, 219-228.
13. Thompson, C. B. (1995). Apoptosis in the pathogenesis and treatment of disease. Science 267, 1456-1462.
14. Jenne, D. E., and Tschopp, J. (1989). Granzymes: A family of serine proteases in granules of cytolytic T Lymphocytes. Curr. Top. Microbiol. Immunol. 140, 33-34.
15. Darmon, A. J., Ehrman, N., Caputo, A., Fujinaga, J., and Bleackley, R. C. (1994). The cytotoxic T cell proteinase granzyme B does not activate interleukin-1-beta-converting enzyme. J Biol. Chem. 269, 32043-32046.
16. Yamatsuji, T., Matsui, T., Okamoto, T., Komatsuzaki, K., et al. (1996). G-protein-mediated neuronal DNA fragmentation induced by familial Alzheimers disease-associated mutants of APP. Science 272, 1349-1352.
17. Goldberg, Y. P., Nicholson, D. W., Rasper, D. M., Kalchman, M. A., Koide, H. B., Graham, R. K., Bromm, M., Kazemi-Esfarjani, P., Thornberry, N. A., Vaillancourt, J. P., and Hayden, M. R. (1996). Cleavage of Huntington by apopain, a proapoptotic cysteine protease, is modulated by the polyglutamine tract. Nat. Gen. 13, 442-449.
18. Marx, J. (1996). Mutant enzyme provides new insights into the cause of ALS. Science 271, 446-447.
19. Ishizaki, Y., Jacobson, M. D., and Raff, M. C. (1998). A role for caspases in lens fiber differentiation. J. Cell Biol. 140, 153-158.
20. Fernandes-Alnemri, T., Takahashi, A., Armstrong, R., Krebs, J., Fritz, L., Tomaselli, K. J., Wang, L., Yu, Z., Croce, C. M., Salveson, G. et al. (1995). Mch3, a novel human apoptotic cysteine protease highly related to CPP32. Cancer Res. 55, 6045-6052.
21. Schlegel, J., Peters, I., Orrenius, S., Miller, D. K., Thornberry, N. A., Yamin, T. T., and Nicholson, D. W. (1996). CPP32/Apopain is a key interleukin 1β converting enzyme-like protease involved in Fas-mediated apoptosis. J. Biol Chem. 271, 1841-1844.
22. Cerretti, D. P., Kozlosky, C. J., Mosley, B., Nelson, N., Van Ness, K., Greenstreet, T. A., March, C. J., Kronheim, S. R., Druck, T., Cannizzaro, L. A., Huebner, K., and Black, R. A. (1992). Molecular cloning of the interleukin-1β converting enzyme. Science 256, 97-100.
23. Nicholson, D. W., Ambereen, A. N., Thornberry, N. A., Vaillancourt, J. P., Ding, C. K., Gallant, M., Gareau, Y., Griffin, P. R., Labelle, M., Lazebnik, Y. A., Munday, N. A., Raju, S. M., Smulson, M. E., Yamin, T. T., Yu, V. L., and Miller, D. K. (1995). Identification and inhibition of the ICE/CED-3 protease necessary for mammalian apoptosis. Nature 376, 37-43.
24. Thornberry, N. A., Bull, H. G., Calaycay, J. R., Chapman, K. T., Howard, A. D., Kostura, M. J., Miller, D. K., Molineaux, S. M., Weidner, J. R., Aunins, J., Elliston, K. O., Ayala, J. M., Casano, F. J., Chin, J., Ding, G. F., Egger, L. A., Gaffney, E. P., Limjuco, G., Palyha, O. C., Raju, S. M., Rolando, A. M., Salley, J. P., Yamin, T. T., Lee, T. D., Shively, J. E., MacCross, M., Mumford, R. A., Schmidt, J. A., and Tocci, M. J. (1992). A novel heterodimeric cysteine protease is required for interleukin-1β processing in monocytes. Nature 356, 768-774.
25. Talanian, R. V., Quinlan, C., Trautz, S., Hackett, M. C., Mankovich, J. A., Banach, D., Ghayur, T., Brady, K. D., and Wong, W. W. (1997). Substrate specificities of caspase family proteases. J. Biol. Chem. 272, 9677-9682.
26. Tewari, M., Quan, L. T., O'Rourke, K., Desnoyers, S., Zeng, Z., Beidler, D. R., Poirier, G. G., Salvesen, G. S., and Dixit, V. M. (1995). Yama/CPP32β, a mammalian homolog of CED-3, is a crmA-inhibitable protease that cleaves the death substrate poly(ADP-ribose) polymerase. Cell 81, 801-809.
27. Fernandes-Alnemri, T., Litwack, G., and Alnemri, E. S. (1994). CPP32, a novel human apoptotic protein with homology to Caenorhabditis elegans cell death protein Ced-3 and mammalian 1-β converting enzyme. J. Biol. Chem. 269, 30761-30764.
28. Lazebnik, Y. A., Kaufman, S. H., Desnoyers, S., Poirier, G. G., and Earnshaw, W. C. (1994). Cleavage of poly (ADP-ribose) polymerase by a proteinase with properties like ICE. Nature 371, 346-347.
29. Martin, S. J., O'Brien, G. A., Nishioka, W. K., McGahon, A. J., Mahboubi, A., Saido, T. C., and Green, D. R. (1995). Proteolysis of fodrin during apoptosis. J. Biol. Chem. 270, 6425-6428.
30. Nath, R., Raser, K. J., Stafford, D., Hajimohammadreza, I., Posner, A., Allen, H., Talanian, R. V., Yuen, P. Y., Gilbertsen, R. B., and Wang, K. K. W. (1996). Non-erythoid α-spectrin breakdown by calpain and interleukin 1β-converting-enzyme-like-protease(s) in apoptotic cells: Contributory roles of both protease families in neuronal apoptosis. Biochem. J. 319, 683-690.
31. Wang, X., Zelenski, N. G., Yang, J., Sakai, J., Brown, M. S., and Goldstein, J. L. (1996). Cleavage of sterol regulatory element binding proteins (SREBPs) by CPP32 during apoptosis. EMBO J. 15, 1012-1020.
32. Casciola-Rosen, L., Nicholson, D. W., Chong, T., Rowan, K. R., Thornberry, N. A., Miller, D. K., and Rosen, A. (1996). Apopain/ CPP32 cleaves proteins that are essential for cellular repair: A fundamental principle of apoptotic death. J. Exp. Med. 183, 1957-1964.
33. Cantrell, D. (1996). T cell antigen receptor signal transduction pathways. Annu. Rev. Immunol. 14, 259-274.
34. Tsutsumi, A., Kubo, M., Fujii, H., Freire-Moar, J., Turck, C. W., and Ransom, J. T. (1993). Regulation of protein kinase C isoform proteins in phorbol ester-stimulated Jurkat T lymphoma cells. J. Immunol. 50, 1746-1754.
35. Barja, P., Alavi-Nassab, A., Turck, C. W., and Freire-Moar, J. (1994). Inhibition of T cell activation by protein kinase C pseudosubstrates. Cell Immunol. 153, 28-38.
36. Pastor, M. I., Woodrow, M., and Cantrell, D. (1995). Regulation and function of P21 Ras in T-lymphocytes. Cancer Surv. 22, 75-83.
37. Smith, K. A. A. (1984). Interleukin 2. Annu. Rev. Immunol. 2, 319-333.
38. Mary, D., Aussel, C., Ferrua, B., and Fehlmann, M. (1987). Regulation of interleukin 2 synthesis by cAMP in Human T-cells. Immunology 139, 1179-1184.
39. Tigges, M. A., Casey, L. S., and Koshland, M. E. (1989). Mechanism of interleukin-2 signaling: Mediation of different outcomes by a single receptor and transduction pathway. Science 243, 781-786.
40. Smith, K. A. A. (1988). Interleukin-2: Inception, impact, and implications. Science 240, 1169-1176.
41. 1 Aspartate-based peptide α-((2,6-dichlorobenzoyl)oxy)methyl keytones as potent time dependent inhibitors of interleukin-1β-converting enzyme. J. Med. Chem. 37, 563-564.
42. Posmantur, R., McGinnis, K., Nadimpalli, R., Gilbertsen, R. B., and Wang, K. K. W. (1997). Characterization of CPP32-like protease activity following apoptotic challenge in SH-SY5Y neuroblastoma cells. J. Neurochem. 68, 2328-2337.
43. Posmantur, R., Wang, K. K. W., Nath, R., and Gilbertsen, R. B. (1997). A purine nucleoside phosphorylase (PNP) inhibitor induces apoptosis via caspase-3-like protease activity in MOLT-4 T cells. Immunopharmacology 37, 231-244.
44. Wang, K. K. W., Nath, R., Posner, A., Raser, K., et al. (1996). An alpha-mercaptoacrylic acid derivative is a selective nonpeptide cell-permeable calpain inhibitor and is neuroprotective. Proc. Natl. Acad. Sci. USA 93, 6686-6692.
45. Zhivotovsky, B., Burgess, D. H., Schlegel, J., Porn, M. I., Vanags, D., and Orrenius, S. (1997). Proteases in fas-mediated apoptosis. J. Cell. Biochem. 64, 43-49.
46. Souness, J. E., Houghton, C., Sardar, N., and Withnall, M. T. (1997). Evidence that cyclic AMP phosphodiesterase inhibitors suppress interleukin-2 release from murine splenocytes by interacting with a 'low-affinity' phosphodiesterase 4 conformer. Br. J. Pharmacol. 121, 743-750.
47. Hivroz-Burgaud, C., and Cantrell, D. A. (1992). Interleukin 2 In "Interleukin-2" (J. Waxman and F. Balkwill, Eds.), pp. 1-11, Blackwell Sci., Oxford.
48. Gamen, S., Marzo, I., Anel, A., Pineiro, A., and Naval, J. (1996). CPP32 inhibition prevents Fas-induced ceramide generation and apoptosis in human cells. FEBS Lett. 390, 232-237.
49. Wilhelm, S., Wagner, H., and Häcker, G. (1998). Activation of caspase-3-like enzymes in non-apoptotic T cells. Eur. J. Immunol. 28, 891-900.
50. Zhang, J., Cado, D., Chen, A., Kabra, N. H., and Winoto, A. (1998). Fas-mediated apoptosis and activation-induced T-cell proliferation are defective in mice lacking FADD/Mort1. Nature 392, 296-300.
51. Widmann, C., Gibson, S., and Johnson, G. L. (1998). Caspase-dependent cleavage of signaling proteins during apoptosis. J. Biol Chem. 273, 7141-7147.
52. Dumont, F. J., Staruch, M. J., Fischer, P., DaSilva, C., and Camacho, R. (1998). Inhibition of T-cell activation by pharmacologic disruption of the MEK1/ERK MAP kinase or calcineurin signaling pathways results in differential modulation of cytokine production. J. Immunol. 160, 2579-2589.
53. Zenner, G., Dirk zur Hausen, J., Burn, J., and Mutelin, T. (1995). Towards unraveling the complexity of T-cell signal transduction. BioEssays 17, 967-975.
54. Zhang, Y., Center, D. M., Wu, M. H., Cruikshank, W. W., Yuan, J., Andrews, D. W., and Kornfeld, H. (1998). Processing and activation of pro-interleukin-16 by caspase-3. J. Biol. Chem. 273, 1144-1149.